Aspergillus citrinoterreus, a new species of section terrei isolated from samples of patients with nonhematological predisposing conditions

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 611-617

  Guinea, Jesús ^a,b,c,d   Sandoval Denis, Marcelo ^e   Escribano, Pilar ^a,b,c   Peláez, Teresa ^a,b,c,d   Guarro, Josep ^e   Bouza, Emilio ^a,b,c,d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d SCHOOL OF MEDICINE   (Spain)

^e FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BETA TUBULIN; CALMODULIN; GENOMIC DNA; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA; PIGMENT; RIBOSOMAL SPACER DNA; TUBULIN;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS CITRINOTERREUS; ASPERGILLUS FLAVIPES; ASPERGILLUS NEONIVEUS; ASPERGILLUS TERREUS SENSU STRICTO; BONE MARROW TRANSPLANTATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLADISTICS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGAL STRUCTURES; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVASIVE ASPERGILLOSIS; LIVER CIRRHOSIS; LUNG ASPERGILLOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES IDENTIFICATION; ASPERGILLOSIS; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY; PHYSIOLOGY;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CALMODULIN; CLUSTER ANALYSIS; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PIGMENTS, BIOLOGICAL; SEQUENCE ANALYSIS, DNA; TUBULIN;

EID: 84921737286     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03088-14     Document Type: Article

References (31)

1. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. 2008. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 47:1041-1050. http://dx.doi.org/10.1086/591969.
2. Le Bourgeois M, Sermet I, Bailly-Botuha C, Delacourt C, de Blic J. 2011. Fungal infections in cystic fibrosis. Arch Pediatr 18(Suppl 1):S15-S21. http://dx.doi.org/10.1016/S0929-693X(11)70936-8.
3. Guinea J, Torres-Narbona M, Gijon P, Muñoz P, Pozo F, Pelaez T, de Miguel J, Bouza E. 2010. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870-877. http://dx.doi.org/10.1111/j.1469-0691.2009.03015.x.
4. Lass-Flörl C, Griff K, Mayr A, Petzer A, Gastl G, Bonatti H, Freund M, Kropshofer G, Dierich MP, Nachbaur D. 2005. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 131:201-207. http://dx.doi.org/10.1111/j.1365-2141.2005.05763.x.
5. Rüping MJ, Gerlach S, Fischer G, Lass-Flörl C, Hellmich M, Veh-reschild JJ, Cornely OA. 2011. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study. J Hosp Infect 78:226-230. http://dx.doi.org/10.1016/j.jhin.2011.01.020.
6. Hachem RY, Kontoyiannis DP, Boktour MR, Afif C, Cooksley C, Bodey GP, Chatzinikolaou I, Perego C, Kantarjian HM, Raad II. 2004. Asper-gillus terreus:anemerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 101:1594-1600. http://dx.doi.org/10.1002/cncr.20554.
7. Steinbach WJ, Benjamin DK, Jr, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. 2004. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 39:192-198. http://dx.doi.org/10.1086/421950.
8. Lass-Flörl C, Grif K, Kontoyiannis DP. 2007. Molecular typing of Asper-gillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol 45:2686-2690. http://dx.doi.org/10.1128/JCM.00917-07.
9. Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, Guarro J, Haase G, Kibbler CC, Meyer W, O'Donnell K, Petti CA, Rodriguez-Tudela JL, Sutton D, Velegraki A, Wickes BL. 2009. Sequence-based identification of Aspergillus, Fusarium, and Muco-rales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 47:877-884. http://dx.doi.org/10.1128/JCM.01685-08.
10. Escribano P, Pelaez T, Muñoz P, Bouza E, Guinea J. 2013. Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob Agents Chemother 57:2815-2820. http://dx.doi.org/10.1128/AAC.02487-12.
11. Gonçalves SS, Stchigel AM, Cano J, Guarro J, Colombo AL. 2013. In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi. Antimicrob Agents Chemother 57:1944-1947. http://dx.doi.org/10.1128/AAC.01902-12.
12. Samson RA, Peterson SW, Frisvad JC, Varga J. 2011. New species in Aspergillussection Terrei. Stud Mycol 69:39-55. http://dx.doi.org/10.3114/sim.2011.69.04.
13. Escribano P, Pelaez T, Recio S, Bouza E, Guinea J. 2012. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibilitytoazoles and amphotericinB. Clin Microbiol Infect 18:E24-E26. http://dx.doi.org/10.1111/j.1469-0691.2011.03714.x.
14. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1821. http://dx.doi.org/10.1086/588660.
15. Bulpa P, Dive A, Sibille Y. 2007. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30:782-800. http://dx.doi.org/10.1183/09031936.00062206.
16. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
17. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680. http://dx.doi.org/10.1093/nar/22.22.4673.
18. Huelsenbeck JP, Ronquist F, Nielsen R, Bollback JP. 2001. Bayesian inference of phylogenetic trees. Bioinformatics 17:754-755. http://dx.doi.org/10.1093/bioinformatics/17.8.754.
19. Nylander J. 2004. MrModelTest v2. Evolutionary Biology Center, Uppsala University, Uppsala, Sweden.
20. Kornerup A, Wanscher JH. 1978. Methuen handbook of colour, 3rd edition, p 251. Hastings House, New York, NY.
21. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. CLSI document M38-A2 Clinical and Laboratory Standards Institute, Wayne, PA.
22. Balajee SA, Baddley JW, Peterson SW, Nickle D, Varga J, Boey A, Lass-Flörl C, Frisvad JC, Samson RA. 2009. Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell 8:713-722. http://dx.doi.org/10.1128/EC.00272-08.
23. Blochwitz A. 1934. Die Gattung Aspergillus. III. Neue Spezies, Varianten und Mutanten der Konidienfarbe, Synonyme und interessante Standorte. Ann Mycol 32:83-89.
24. Thom C, Raper K (ed). 1945. Manual of aspergilli, p 195-205. Williams and Wilkins, Baltimore, MD.
25. Raper K, Fennell D (ed). 1977. The genus Aspergillus, p 567-577. Robert E. Krieger Publishing Company, Huntington, NY.
26. Arabatzis M, Velegraki A. 2013. Sexual reproduction in the opportunistic human pathogen Aspergillus terreus. Mycologia 105:71-79. http://dx.doi.org/10.3852/11-426.
27. Taylor JW, Jacobson DJ, Kroken S, Kasuga T, Geiser DM, Hibbett DS, Fisher MC. 2000. Phylogenetic species recognition and species concepts in fungi. Fungal Genet Biol 31:21-32. http://dx.doi.org/10.1006/fgbi.2000.1228.
28. Dettman JR, Jacobson DJ, Turner E, Pringle A, Taylor JW. 2003. Reproductive isolation and phylogenetic divergence in Neurospora: comparing methods of species recognition in a model eukaryote. Evolution 57:2721-2741. http://dx.doi.org/10.1554/03-074.
29. Lass-Flörl C, Kofler G, Kropshofer G, Hermans J, Kreczy A, Dierich MP, Niederwieser D. 1998. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 42:497-502. http://dx.doi.org/10.1093/jac/42.4.497.
30. Steinbach WJ, Perfect JR, Schell WA, Walsh TJ, Benjamin DK, Jr. 2004. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergil-lus terreus infection. Antimicrob Agents Chemother 48:3217-3225. http://dx.doi.org/10.1128/AAC.48.9.3217-3225.2004.
31. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327-360. http://dx.doi.org/10.1086/525258.